{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:00:27Z","timestamp":1785333627642,"version":"3.55.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930089"],"award-info":[{"award-number":["81930089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630082"],"award-info":[{"award-number":["81630082"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jdin.2026.01.006","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T16:08:38Z","timestamp":1769875718000},"page":"105-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Interleukin-17A inhibitors for guttate psoriasis treatment: A retrospective cohort study"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3331-5538","authenticated-orcid":false,"given":"Xiao-yong","family":"Man","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2925-209X","authenticated-orcid":false,"given":"Gao-yuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ran","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jdin.2026.01.006_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000527737","article-title":"New-onset guttate psoriasis: a long-term follow-up study","volume":"239","author":"Galili","year":"2023","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.jdin.2026.01.006_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaad.2024.04.082","article-title":"The risk of different subtypes of psoriasis following an episode of guttate psoriasis","volume":"92","author":"Kridin","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2026.01.006_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/bjd\/ljae481","article-title":"Rapid and sustained response of stubborn guttate psoriasis to ustekinumab: a 52-week, two-centre, one-arm observational study","volume":"192","author":"Chen","year":"2025","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2026.01.006_bib4","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jaad.2025.08.017","article-title":"Sustained remission of guttate psoriasis flares with short-term interleukin-23 inhibition: a case series","volume":"93","author":"Hodelin","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jdin.2026.01.006_bib5","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/ijd.15478","article-title":"Durable remissions of guttate psoriasis following short courses of IL-17 inhibitors","volume":"60","author":"Printy","year":"2021","journal-title":"Int J Dermatol"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328726000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328726000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:07:17Z","timestamp":1777601237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328726000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":5,"alternative-id":["S2666328726000106"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2026.01.006","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-17A inhibitors for guttate psoriasis treatment: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2026.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}